1-3 of 3
Philip Kuruvilla
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tailor: Interventional Study Evaluating Physician's Choice of Ibrutinib Monotherapy or Ibrutinib-Venetoclax Combination Using Dose Modifications and Alternate Dosing Approaches in Patients with Untreated Chronic Lymphocytic Leukemia

Jeff P. Sharman, Jan A. Burger, Jacqueline Barrientos, Philip Kuruvilla, Sima Patel, Gabriel Krigsfeld, Sowmya Srikanthan, Bothayna Messahel, Wasiulla Khan, Emma Smith, Paolo Ghia
Journal: Blood
Blood (2023) 142 (Supplement 1): 6564.
https://doi.org/10.1182/blood-2023-174751
Published: 2023
Journal Articles

Real World Experience of Ibrutinib in an Ethnically Diverse Canadian Community Hospital

Philip Kuruvilla, Juhi Husain, Henry J. Conter, William To-Dang, Margaret Balcewicz, Stephen Reingold
Journal: Blood
Blood (2023) 142 (Supplement 1): 6549.
https://doi.org/10.1182/blood-2023-172977
Published: 2023
Journal Articles

A Real-World Canadian Experience of Asciminib Use in Chronic Myeloid Leukemia (CML) Patients Who Failed Multiple Lines of Tyrosine Kinase Inhibitor (TKI) Therapy

Fatima Khadadah, Anargyros Xenocostas, Lambert Busque, Kareem Jamani, Sonia Cerquozzi, Philip Kuruvilla, Brian Leber, Rayan Kaedbey, Sarit Assouline, Dennis Dong Hwan Kim
Journal: Blood
Blood (2021) 138 (Supplement 1): 3610.
https://doi.org/10.1182/blood-2021-149588
Published: 2021